ArticleTranslational lung cancer research2022

Safety and efficacy of nivolumab plus recombinant human endostatin in previously treated advanced non-small-cell lung cancer.

Weize Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.